Latest Strategic Projects News

Scorpion Minerals has addressed recent spikes in its share price and trading volume, attributing the activity to rising global gold prices and imminent assay results from its Pharos Gold Project.

Podium Minerals has launched a A$12 million capital raising to accelerate development at its Parks Reef platinum group metals project, following a key metallurgical breakthrough and resource upgrades.

Mont Royal Resources Ltd has lodged a replacement prospectus to raise between A$8 million and A$10 million, supporting its merger with Commerce Resources Corp and advancing critical minerals projects in Quebec, Canada.

Beonic Ltd has raised $4.27 million through convertible notes to fund its product development, repay upcoming debt, and advance its North African Airport Project.

Auravelle Resources reports standout high-grade gold results from its South Australian projects and outlines a robust exploration agenda targeting major gold deposits nearby.

Summit Minerals announces a $1.67 million capital raise through a Placement and a fully underwritten Rights Issue, aiming to accelerate exploration in Brazil and pursue new project opportunities.

BPM Minerals has secured a Heritage Agreement with traditional owners at its Forelands Gold Project, clearing the way for a maiden drilling program targeting high-grade gold prospects. The company’s strengthened balance sheet and expert team set the stage for a promising exploration phase.

Enova Mining has narrowed its half-year loss to $1.07 million while progressing key rare earth and lithium projects in Brazil and Australia, supported by recent capital raises totaling $2.35 million.

Great Northern Minerals has significantly expanded its Catalyst Ridge rare earth and antimony project in California’s Mountain Pass District by applying for 96 additional lode claims, positioning itself strongly within a critical US minerals hub.

Euro Manganese Inc. reports significant progress on its Chvaletice Project and Bécancour Plant, positioning itself as a key Western supplier of high-purity manganese critical for EV batteries. The company highlights strong feasibility results, strategic financing partnerships, and multiple offtake agreements amid an expected global supply deficit.

Chimeric Therapeutics reported a reduced net loss of $10.43 million for FY2025, driven by cost efficiencies and strategic project reprioritisation, while making significant clinical progress in its CAR T-cell and NK cell therapy programs.

DTI Group Ltd reported an 11% revenue increase and secured a $4 million Adelaide Metro contract, alongside a $2.69 million capital raise to fuel growth. The company also deepened global partnerships and enhanced its technology platform during FY25.